Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients.
about
A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell deathParkin mono-ubiquitinates Bcl-2 and regulates autophagyParkin accumulation in aggresomes due to proteasome impairmentParkin-dependent degradation of the F-box protein Fbw7β promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1Parkin is recruited selectively to impaired mitochondria and promotes their autophagyExcitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brainsIdentification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partnerLocalization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryOxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells14-3-3eta is a novel regulator of parkin ubiquitin ligase.Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpainLewy bodies and parkinsonism in families with parkin mutationsDevelopmental changes in the expression of parkin and UbcR7, a parkin-interacting and ubiquitin-conjugating enzyme, in rat brainCloning of rat parkin cDNA and distribution of parkin in rat brainParkin promotes degradation of the mitochondrial pro-apoptotic ARTS proteinMitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARLThe Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in DrosophilaBehavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes.Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Parkin regulation of CHOP modulates susceptibility to cardiac endoplasmic reticulum stress.Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implicationsAlternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.Failure of the ubiquitin-proteasome system in Parkinson's disease.A meta-analysis of the relationship of the Parkin p.Val380Leu polymorphism to Parkinson's disease.Profiling of Parkin-binding partners using tandem affinity purification.Parkin mediates the degradation-independent ubiquitination of Hsp70Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.Lipid profiling of parkin-mutant human skin fibroblasts.Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's diseaseExpanding insights of mitochondrial dysfunction in Parkinson's disease.Editorial: Golgi Pathology in Neurodegenerative Diseases.Recessive Parkinson's disease.The role of ubiquitin-protein ligases in neurodegenerative disease.Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress.Genome-wide analysis of copy number variations identifies PARK2 as a candidate gene for autism spectrum disorder.Genetics of iron regulation and the possible role of iron in Parkinson's disease.Protein degradation in Parkinson disease revisited: it's complex
P2860
Q24297163-2F46C8B3-E733-468D-B718-B4A0855B7520Q24301563-CEAE62AC-74F0-43A9-A6FB-A95AB2AF8C33Q24308757-775BBF13-ED5B-46AD-B9B2-C79EED26A722Q24308897-E887D1EA-5616-423E-9A55-E2725D7FBB33Q24317471-E839BF5D-3392-4206-9B1A-D676051BE557Q24338463-1058E898-48A2-42FF-9444-A99680EE7BEFQ24339313-F7963C04-0E65-45EA-ABC2-E21E96693839Q24536382-09FA3BC7-F870-4975-9217-094CF48B0FADQ24630927-EDBB12B2-B322-46D6-B9E8-A9028173B8FDQ27024171-92209436-1BC0-45E2-B6F8-380C1683532EQ28115387-497BB5FC-0DAB-411D-B664-0D5297E6AF99Q28201602-12120FE6-FD4C-4A26-A5D0-090668791925Q28216308-DA5B45D0-C6DF-4DC7-815E-21DD44A3289BQ28568381-9E5A8DA4-51F4-439F-9778-C8439571BACBQ28576408-EA9FC5A2-C5DC-4C6B-B987-BCBC9E26E5F8Q28727358-A872C959-CE34-413F-95CF-83CA936ACB02Q29615624-EBF54A66-DB45-4292-8D22-4A82FD8ABB3CQ29617091-2FAF934A-55FB-43F6-9C59-6184AC40F366Q30444939-D57A7CB8-BF00-4D3A-AEAE-5A5465B469EAQ32160935-4637425F-9A6F-4C7F-8EC4-2E09B9347855Q33364885-5579B03A-BD54-4EAC-8B55-819C633EE4D9Q33704728-2C05E189-CD89-4BCC-9FF1-AECA9D6BB350Q34012297-622FA859-B868-4ABA-92CA-25F69B2D90D6Q34014415-CB595D16-B313-425E-BAB9-BCB9E8019737Q34325371-9EABD9D2-AE1F-4449-9CAC-CCD9C496122BQ34597756-D5F969AD-C4F7-465A-8F81-22590A9AFF9AQ35045403-317405AD-5A7E-4D00-A3B9-51F63623A60FQ35609973-7E19755B-4391-4BB6-A4FD-5E11AC8CAAC6Q35748069-26781ED6-6431-46B5-82F7-C65087200EDAQ35897729-E3658D86-849A-417D-B3CD-06F1CBAF5329Q36256274-E3DA774E-7FD6-4F84-83AC-6F6EFAB2E876Q36336839-FC7337F5-4985-4468-93B3-BC296B443D6AQ36404133-EC0524D5-114E-4884-9162-112D12270FCAQ36431899-690CC7DA-AB01-4240-8EAC-AD5E2CCFFFA3Q36449306-3CFD00A5-B0BB-4609-9D95-65A84B6CFC6FQ36565602-EE418C12-A402-4693-A346-5B8348C7CDA2Q36655956-87BB6885-C5BF-40B7-B9B4-481B382DF91FQ36758369-48D093EF-9883-44E2-9805-20BB89E71113Q36815145-6B118619-4D68-47E3-BDE8-7946B00099D5Q37111325-E8A8091B-A760-4AAC-A266-EF25426231B2
P2860
Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@ast
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@en
type
label
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@ast
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@en
prefLabel
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@ast
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@en
P2093
P2860
P1433
P1476
Immunohistochemical and subcel ...... uvenile parkinsonism patients.
@en
P2093
H Matsumine
M Yoshikawa
S Minoshima
P2860
P304
P356
10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
P577
1999-05-01T00:00:00Z